Literature DB >> 25483535

Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.

Ana Martínez1, Sonia Broner, M Rosa Sala, Sandra Manzanares-Laya, Pere Godoy, Caritat Planas, Sofia Minguell, Nuria Torner, Mireia Jané, Angela Domínguez, The Working Group For The Study Of The Immune Status In Health Care, For The Study Of Hepatitis A In Catalonia.   

Abstract

A hepatitis A+B vaccine vaccination program of 12-year-olds was introduced in Catalonia in 1998. The aim of this study was to investigate the evolution of hepatitis A outbreaks in Catalonia and estimate the preventable fraction of cases associated with outbreaks as a measure of the impact of the vaccination program. Hepatitis A outbreaks reported to the Health Department between 1991 and 2012 were analyzed. The incidence rates of outbreaks, outbreak-associated cases and hospitalizations were calculated. The preventable fraction (PF) and 95% confidence intervals (CI) were estimated for the whole study period (pre-vaccination and post-vaccination) and the post-vaccination period.   One-hundred-eight (108) outbreaks (rate of 2.21 per 10(6) persons-year) were reported in the pre-vaccination period and 258 outbreaks (rate of 2.82 per 10(6) persons-year) in the post-vaccination period. The rate of cases associated with outbreaks was 1.52 per 10(5) persons-year in the pre-vaccination period and 1.28 per 10(5) persons-year in the post-vaccination period. Hospitalization rates were 0.08 and 0.75 per 10(6) persons-year, respectively. The number of person-to-person outbreaks whose index case was a school contact decreased in the post-vaccination period (aOR 2.72; 95%CI 1.35-5.48), but outbreaks whose index case was a man who has sex with men (MSM) or an immigrant increased. The PF of all outbreak-associated cases was 6.46% (95%CI 3.11-9.82) and the highest PF was in the 15-24 years age group (42.53%; 95%CI 29.30-55.75). In the 0-4 years age group, the PF was 18.35% (95%CI 9.59-27.11), suggesting a protective herd effect in unvaccinated subjects. Vaccination of immigrants traveling to endemic countries and MSM should be reinforced.

Entities:  

Keywords:  Hepatitis A; hospitalization; incidence rate; mass immunization program; outbreak; preventable fraction

Mesh:

Substances:

Year:  2014        PMID: 25483535      PMCID: PMC4514321          DOI: 10.4161/hv.35861

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  35 in total

1.  Epidemiology of hepatitis A in Finland in 1990-2007.

Authors:  Mia Broman; Sari Jokinen; Markku Kuusi; Maija Lappalainen; Merja Roivainen; Kirsi Liitsola; Irja Davidkin
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

2.  Hepatitis A in men having sex with men (MSMs) in northern Italy.

Authors:  Alessandro Pini; Lina Rachele Tomasoni; Graziella Cristini; Massimo Puoti; Alberto Matteelli; Giampiero Carosi; Francesco Castelli
Journal:  Infez Med       Date:  2010-06

3.  Outbreak of hepatitis A among men who have sex with men in Barcelona, Spain, September 2008-March 2009.

Authors:  C Tortajada; P G de Olalla; R M Pinto; A Bosch; J Caylà
Journal:  Euro Surveill       Date:  2009-04-16

4.  Immunity to hepatitis A when outbreaks of infection in men who have sex with men (MSM) are rare.

Authors:  Ajith P Weerakoon; Marcus Y Chen; Tim R H Read; Catriona Bradshaw; Christopher K Fairley
Journal:  Vaccine       Date:  2012-03-23       Impact factor: 3.641

5.  Hepatitis A among men who have sex with men in Barcelona, 1989-2010: insufficient control and need for new approaches.

Authors:  Cecilia Tortajada; Patricia G de Olalla; Elia Diez; Rosa M Pinto; Albert Bosch; Unai Perez; Milagros Sanz; Joan A Caylà
Journal:  BMC Infect Dis       Date:  2012-01-20       Impact factor: 3.090

6.  Changes in the epidemiology of hepatitis A in Spain (2005–2008): trends of acute hepatitis A hospitalizations, comorbidities, and costs associated with the hospitalization.

Authors:  Alejandro Arteaga-Rodríguez; Pilar Carrasco-Garrido; Ana López de Andrés; Angel Gil de Miguel; Juana Santos; Rodrigo Jiménez-García
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-11       Impact factor: 2.566

7.  Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995-2008.

Authors:  Tsung-Pei Tsou; Cheng-Chung Liu; Ji-Jia Huang; Kun-Ju Tsai; Hsiu-Fang Chang
Journal:  Vaccine       Date:  2011-02-15       Impact factor: 3.641

8.  Hepatitis A and travel amongst Nova Scotia postsecondary students: evidence for a targeted vs. universal immunization strategy.

Authors:  Katherine Matheson; Beth Halperin; Shelly McNeil; Joanne M Langley; Donna Mackinnon-Cameron; Scott A Halperin
Journal:  Vaccine       Date:  2010-10-16       Impact factor: 3.641

9.  Hepatitis A outbreak predominantly affecting men who have sex with men in Northern Ireland, October 2008 to July 2009.

Authors:  O Sfetcu; N Irvine; S L Ngui; C Emerson; C McCaughey; P Donaghy
Journal:  Euro Surveill       Date:  2011-03-03

10.  Acute hepatitis A in a pregnant woman at delivery.

Authors:  Anne Motte; Julie Blanc; Philippe Minodier; Philippe Colson
Journal:  Int J Infect Dis       Date:  2008-09-06       Impact factor: 3.623

View more
  6 in total

1.  Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction.

Authors:  Domenico Martinelli; Francesca Fortunato; Maria Giovanna Cappelli; Vanessa Cozza; Maria Chironna; Rosa Prato
Journal:  J Immunol Res       Date:  2015-08-17       Impact factor: 4.818

2.  Human immunodeficiency virus and liver disease: A comprehensive update.

Authors:  Kenneth E Sherman; Marion G Peters; David Thomas
Journal:  Hepatol Commun       Date:  2017-11-06

Review 3.  Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review.

Authors:  Anke L Stuurman; Cinzia Marano; Eveline M Bunge; Laurence De Moerlooze; Daniel Shouval
Journal:  Hum Vaccin Immunother       Date:  2016-10-27       Impact factor: 3.452

4.  Epidemiology of hepatitis A in Greece in the last decade: management of reported cases and outbreaks and lessons learned.

Authors:  K Mellou; A Chrysostomou; T Sideroglou; M Kyritsi; T Georgakopoulou; S Tsiodras; C Hadjichristodoulou
Journal:  Epidemiol Infect       Date:  2020-02-13       Impact factor: 2.451

Review 5.  Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.

Authors:  Christian Herzog; Koen Van Herck; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

6.  Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.

Authors:  Pierre Van Damme; Geert Leroux-Roels; P Suryakiran; Nicolas Folschweiller; Olivier Van Der Meeren
Journal:  Hum Vaccin Immunother       Date:  2017-03-10       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.